Dr. Shilpa Gupta, MD
Claim this profileCleveland Clinic Foundation
Studies Cancer
Studies Bladder Cancer
10 reported clinical trials
20 drugs studied
Area of expertise
1Cancer
Stage IV
Stage III
Stage II
2Bladder Cancer
Stage IV
Stage III
Stage II
Affiliated Hospitals
Clinical Trials Shilpa Gupta, MD is currently running
ACR-368
for Ovarian Cancer
This trial tests a new drug, ACR-368, alone or with a small dose of another drug, gemcitabine, in patients whose cancers don't respond to standard treatments. A special test helps decide which treatment might work best for each patient. Gemcitabine has been used with other drugs for various cancers, including pancreatic, lung, ovarian, and breast cancers.
Recruiting1 award Phase 1 & 210 criteria
FX-909
for Bladder Cancer
This trial tests a new tablet called FX-909 for safety and proper dosage in patients with advanced solid tumors, especially advanced urothelial carcinoma. Doctors will closely monitor patients to understand how the drug works and its effects on the body and tumors.
Recruiting1 award Phase 1
More about Shilpa Gupta, MD
Clinical Trial Related2 years of experience running clinical trials · Led 10 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Shilpa Gupta, MD has experience with
- Cisplatin
- Gemcitabine
- Gemcitabine Hydrochloride
- Avelumab
- Nivolumab
- TAK-228
Breakdown of trials Shilpa Gupta, MD has run
Cancer
- ACR-368 for Ovarian Cancer
- FX-909 for Bladder Cancer
- Testing the Addition of an Anti-Cancer Immunotherapy Drug, Avelumab, to Gemcitabine and Carboplatin Chemotherapy Prior to Surgery in Muscle Invasive Urinary Tract Cancer vs. Surgery Alone in Patients Who Are Not Able to Receive Cisplatin Therapy (SWOG GAP TRIAL)
Bladder Cancer
- ACR-368 for Ovarian Cancer
- FX-909 for Bladder Cancer
- Testing the Addition of an Anti-Cancer Immunotherapy Drug, Avelumab, to Gemcitabine and Carboplatin Chemotherapy Prior to Surgery in Muscle Invasive Urinary Tract Cancer vs. Surgery Alone in Patients Who Are Not Able to Receive Cisplatin Therapy (SWOG GAP TRIAL)
Transitional Cell Carcinoma
- ACR-368 for Ovarian Cancer
- FX-909 for Bladder Cancer
- Testing the Addition of an Anti-Cancer Immunotherapy Drug, Avelumab, to Gemcitabine and Carboplatin Chemotherapy Prior to Surgery in Muscle Invasive Urinary Tract Cancer vs. Surgery Alone in Patients Who Are Not Able to Receive Cisplatin Therapy (SWOG GAP TRIAL)
Prostate Cancer
Urothelial Carcinoma
- Testing the Addition of an Anti-Cancer Immunotherapy Drug, Avelumab, to Gemcitabine and Carboplatin Chemotherapy Prior to Surgery in Muscle Invasive Urinary Tract Cancer vs. Surgery Alone in Patients Who Are Not Able to Receive Cisplatin Therapy (SWOG GAP TRIAL)
- Cabozantinib + Avelumab for Bladder Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Shilpa Gupta, MD specialize in?
Shilpa Gupta, MD focuses on Cancer and Bladder Cancer. In particular, much of their work with Cancer has involved Stage IV patients, or patients who are Stage III.
Is Shilpa Gupta, MD currently recruiting for clinical trials?
Yes, Shilpa Gupta, MD is currently recruiting for 3 clinical trials in Cleveland Ohio. If you're interested in participating, you should apply.
Are there any treatments that Shilpa Gupta, MD has studied deeply?
Yes, Shilpa Gupta, MD has studied treatments such as Cisplatin, Gemcitabine, Gemcitabine Hydrochloride.
What is the best way to schedule an appointment with Shilpa Gupta, MD?
Apply for one of the trials that Shilpa Gupta, MD is conducting.
What is the office address of Shilpa Gupta, MD?
The office of Shilpa Gupta, MD is located at: Cleveland Clinic Foundation, Cleveland, Ohio 44195 United States. This is the address for their practice at the Cleveland Clinic Foundation.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.